Displaying 1 - 4 of 4
Contract Number Brand Code Brand Name Active Ingredient Trade Name Package Size Formulary Category Pkg Price Unit Price Unit Description Max. Reimbursable Quantity / Month Package Description Manufacturer Code Manufacturer Name Agent Code Agent Name Benefit Therapeutic Code Therapeutic Desc Drug Contract Start Date Drug Contract End Date Status Description Default Route Max Repeats Therapeutic Head Amend Date
42 B001A APO-CABERGOLINE 0.5MG TAB (APO) CAB CABERGOLINE APO-CABERGOLINE 8'S BQ 27.73 3.47 TAB 32 BOTT APO APOTEX INC. COL AVENTA BARBADOS 283620 DOPAMINE RECEPTOR AGONIST 2026-04-01 ORAL 0 DOPAMINE RECEPTOR AGONIST
40 B001D CABERGOLINE 0.5MG TAB (TMP/AHI) CABERGOLINE CABERGOLINE 4'S BQ 30.83 7.71 TABLET 0 TAB TMP THE MADRAS PHARMACEUTICALS AHI ARMSTRONG HEALTHCARE INC 283620 DOPAMINE RECEPTOR AGONIST 2022-04-01 2024-03-31 Oral 6 CENTRAL NERVOUS SYSTEM DRUGS
41 B001E APO-CABERGOLINE 0.5MG TAB (APO) CAB (C) CABERGOLINE APO-CABERGOLINE 8'S C 27.73 3.4659 TAB 32 BOTT APO APOTEX INC. ATB ANSA TRADING BARBADOS LTD 283620 DOPAMINE RECEPTOR AGONIST 2024-04-01 2026-03-31 ORAL 6 DOPAMINE RECEPTOR AGONIST
42 B001G CABERLEE 0.5MG TAB (JLP) CABERGOLINE CABERGOLINE CABERLEE 40'S BQ 81.55 2.04 TAB 32 BLIS JLP JOHN LEE PHARMACEUTICALS AHI ARMSTRONG HEALTHCARE INC 283620 DOPAMINE RECEPTOR AGONIST 2026-04-01 ORAL 0 DOPAMINE RECEPTOR AGONIST